Stock
Ownership of a fraction of a corporation and the right to claim a share of the corporation's assets and profits equal to the amount of stock owned
US listed security
Listed on NASDAQ
US headquartered
Headquartered in Chatham, New Jersey, United States

Tonix Pharmaceuticals Holding Corp

$1.03
TNXP
After Hours:
$1.04
(0.97%)+$0.01
Closed: Jan 22, 7:59:24 PM GMT-5 · USD · NASDAQ · Disclaimer

In the news

Financial performance
(USD)Q3 2020Year/year change
Revenue
--
Net income
-11.99M-52.97%
Diluted EPS-0.0998.42%
Net profit margin--
Operating income-12.00M-52.06%
Net change in cash775.00K136.45%
Cash on hand55.66M455.25%
Cost of revenue--
About
Tonix Pharmaceuticals is a pharmaceutical company based in New York City that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project. The company's predecessors were Tamandare Explorations Inc. which had been formed in 2007 as a mining wildcat vehicle focused on land in Nevada and the shares of which were traded over the counter, and L & L Technologies, LLC, which had been formed in 1996 by Seth Lederman and Donald Landry to repurpose drugs for CNS development. L&L had formed Janus Pharmaceuticals, Inc., which later became Vela Pharmaceuticals, Inc. to develop some of its inventions, and Vela returned those assets to L&L in 2006. L&L placed them in a subsidiary called Krele Pharmaceuticals, Inc., and that subsidiary and Tamandare Explorations Inc. performed a reverse merger in October 2011; the new entity was renamed Tonix Pharmaceuticals Holding Corp. and Lederman was named CEO. It was listed on the NASDAQ exchange in 2013 under the symbol TNXP. Wikipedia
Founded
2007
Employees
16

Key stats

Previous close
The last closing price
$0.98
Day range
The difference between the high and low prices over the past day
$0.97 - $1.07
Year range
The difference between the high and low prices over the past 52 weeks
$0.39 - $2.46
Market cap
A valuation method that multiplies the price of a company's stock by the total number of outstanding shares.
272.72M USD
Volume
The average number of shares traded each day over the past 30 days
32.99M
P/E ratio
The ratio of current share price to trailing twelve month EPS that signals if the price is high or low compared to other stocks
-
Dividend yield
The ratio of annual dividend to current share price that estimates the dividend return of a stock
-
Primary exchange
Listed exchange for this security
NASDAQ
About
Tonix Pharmaceuticals is a pharmaceutical company based in New York City that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project. The company's predecessors were Tamandare Explorations Inc. which had been formed in 2007 as a mining wildcat vehicle focused on land in Nevada and the shares of which were traded over the counter, and L & L Technologies, LLC, which had been formed in 1996 by Seth Lederman and Donald Landry to repurpose drugs for CNS development. L&L had formed Janus Pharmaceuticals, Inc., which later became Vela Pharmaceuticals, Inc. to develop some of its inventions, and Vela returned those assets to L&L in 2006. L&L placed them in a subsidiary called Krele Pharmaceuticals, Inc., and that subsidiary and Tamandare Explorations Inc. performed a reverse merger in October 2011; the new entity was renamed Tonix Pharmaceuticals Holding Corp. and Lederman was named CEO. It was listed on the NASDAQ exchange in 2013 under the symbol TNXP. Wikipedia
Founded
2007
Employees
16

Discover more

You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more

People also search for

Search
Clear search
Close search
Google apps
Main menu